Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-19
DOI
10.1186/s12885-020-06921-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma
- (2019) Madelyn Burkart et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical utility of the modified Glasgow Prognostic Score to classify cachexia in patients with advanced cancer in palliative care
- (2019) Geisiane Alves da Silva et al. CLINICAL NUTRITION
- Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma
- (2018) Yusuke Kanemasa et al. ANNALS OF HEMATOLOGY
- Geriatric nutritional risk index is not an independent predictor in patients with diffuse large B-cell lymphoma
- (2018) Zhongqi Li et al. Cancer Biomarkers
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
- (2018) Bjoern Chapuy et al. NATURE MEDICINE
- Adipose tissue dysfunction in cancer cachexia
- (2018) Sahar I. Daas et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one
- (2017) Se-Il Go et al. Oncotarget
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex
- (2016) Zheng Zhou et al. Journal of the National Comprehensive Cancer Network
- Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
- (2016) Se-Il Go et al. Journal of Cachexia Sarcopenia and Muscle
- Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy
- (2016) Michael P. Chu et al. Journal of Cachexia Sarcopenia and Muscle
- Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
- (2015) Mohammed Al-Hamadani et al. AMERICAN JOURNAL OF HEMATOLOGY
- Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
- (2015) Nobuhiko Nakamura et al. ANNALS OF HEMATOLOGY
- Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified
- (2015) Hee Sang Hwang et al. ANNALS OF HEMATOLOGY
- Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor
- (2015) Osnat Bairey et al. HEMATOLOGICAL ONCOLOGY
- Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
- (2014) Samir Dalia et al. ANNALS OF HEMATOLOGY
- The role of body mass index in survival outcome for lymphoma patients: US intergroup experience
- (2014) F. Hong et al. ANNALS OF ONCOLOGY
- Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2014) Vincent Camus et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Human serum albumin, systemic inflammation, and cirrhosis
- (2014) Vicente Arroyo et al. JOURNAL OF HEPATOLOGY
- Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)
- (2014) Alessandra Tucci et al. LEUKEMIA & LYMPHOMA
- Effect of Nutritional Status on Survival Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
- (2014) Silvia Park et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) Hélène Lanic et al. LEUKEMIA & LYMPHOMA
- Increased Body Mass Index Is Associated With Improved Survival in United States Veterans With Diffuse Large B-Cell Lymphoma
- (2012) Kenneth R. Carson et al. JOURNAL OF CLINICAL ONCOLOGY
- High Ki67 Index and Bulky Disease Remain Significant Adverse Prognostic Factors in Patients with Diffuse Large B Cell Lymphoma before and after the Introduction of Rituximab
- (2011) Francesco Gaudio et al. ACTA HAEMATOLOGICA
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
- (2010) B. Coiffier et al. BLOOD
- Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
- (2009) Margaret E. Benny Klimek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Muscle myostatin signalling is enhanced in experimental cancer cachexia
- (2008) P. Costelli et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More